Comparative

Disease groups

1,086 disease groups whose chain reached a human disease, by OMIA group number.

OMIA group Name Species The chain reached Best score
497 Hyperbilirubinaemia II 1 Human disease 9.0
499 Hypercholesterolaemia 7 Target evidence 65.5
502 Hypereosinophilic syndrome 4 Human disease 37.5
507 Hyperostosis 1 Human disease 9.0
508 Hyperparathyroidism 4 Human disease 40.0
510 Hypertension, essential 1 Human disease 31.5
511 Hyperthyroidism 4 Human disease 15.0
513 Hypertrichosis 2 Human disease 29.5
514 Hypertriglyceridaemia 2 Human disease 12.0
515 Cardiomyopathy, hypertrophic 8 Human disease 37.5
519 Hypoadrenocorticism 4 Human disease 40.0
522 Hypogonadism 2 Human disease 34.5
528 Hypoparathyroidism 3 Human disease 30.0
536 Hypothyroidism, congenital 8 Human gene 40.0
540 Hypotrichosis, generic 12 Human disease 15.0
542 Hypotrichosis, streaked 1 Human gene 29.0
543 Hypohidrotic ectodermal dysplasia, X-linked, EDA-related 4 Target evidence 85.0
545 Axonopathy, hypotrophic 1 Human disease 9.0
546 Ichthyosis, TGM1-related 1 Human gene 34.0
550 Immunodeficiency 3 Human disease 37.5
552 Immunoglobulin A deficiency 2 Human disease 9.5
556 Immunoglobulin M deficiency 2 Human disease 9.0
564 Difference of sexual development, generic 24 Human disease 15.0
565 Intestinal cobalamin malabsorption, AMN-related 1 Target evidence 54.3
573 Ciliary dyskinesia, primary, generic 3 Human gene 35.0
578 Krabbe disease 4 Target evidence 85.1
586 Legg-Calvé-Perthes disease 5 Human disease 20.0
588 Lens luxation 3 Target evidence 59.7
593 Acrodermatitis enteropathica 3 Target evidence 69.3
595 Leukocyte adhesion deficiency, type I 5 Drug 84.0
615 Lymphosarcoma 3 Human disease 12.5
616 Lysosomal storage disease 6 Human disease 32.5
618 Macrostomus 2 Human disease 12.0
620 Histiocytosis, malignant 8 Human gene 32.5
621 Malignant hyperthermia 8 Human gene 35.0
625 Mannosidosis, alpha 7 Target evidence 95.0
626 Mannosidosis, beta 5 Target evidence 63.9
627 Maple syrup urine disease, BCKDHA-related 1 Target evidence 63.4
628 Marfan syndrome, FBN1-related 4 Target evidence 88.0
629 Megacolon 5 Drug 64.7
633 Melanoma, Sinclair swine cutaneous malignant 1 Human disease 9.0
636 Membranoproliferative glomerulonephritis type II 1 Human gene 29.0
640 Menkes disease 2 Target evidence 88.9
642 Mesangiocapillary glomerulonephritis, type I 1 Human disease 9.0
645 Microcephaly 1 Human disease 6.5
648 Micromelia 3 Human disease 15.0
649 Microphthalmia 11 Target evidence 35.3
653 Mitral stenosis 2 Human disease 29.5
654 Myxomatous valvular degeneration 8 Human disease 15.0
655 Mitral valve stenosis 1 Human disease 26.5